PCG Molecular is a preventive care diagnostic company driven to change national figures concerning disease and survival rates. A proven pioneer in the industry, PCG Molecular is dedicated to the research and development of genetic, molecular screens that detect problems early, are easy to administer, and bring pliable business models to practitioners that incentivize change.
Our company offers physicians, hospitals, and patients more than twenty years of pathology experience with highly-trained, Board Certified pathologists and molecular biologists that understand the unique clinical and business needs within hospital and outpatient settings.